Chandrasekhar V Miduturu

USPTO Granted Patents = 21 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 10)

Average Co-Inventor Count = 3.9

ph-index = 12

Forward Citations = 458(Granted Patents)

Company Filing History:

19 out of 60

Blueprint Medicines Corporation

Dana-farber-cancer Institute Inc.

patents

4. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

21 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12202844 - MAP4K1 inhibitors (2025-01-21),

2. 12042495 - MAP4K1 inhibitors (2024-07-23),

3. 11534441 - MAP4K1 inhibitors (2022-12-27),

4. 11059827 - Compounds and compositions useful for treating disorders related to NTRK (2021-07-13),

5. 11046697 - Compounds and compositions useful for treating disorders related to NTRK (2021-06-29),

6. 10875837 - Inhibitors of the fibroblast growth factor receptor (2020-12-29),

7. 10370379 - Compounds and compositions useful for treating disorders related to NTRK (2019-08-06),

8. 10221154 - Inhibitors of the fibroblast growth factor receptor (2019-03-05),

9. 10196436 - Inhibitors of the fibroblast growth factor receptor (2019-02-05),

10. 10150742 - Substituted heterocyclic compounds for treating or preventing viral infections (2018-12-11),

11. 10017512 - Compounds and compositions useful for treating disorders related to NTRK (2018-07-10),

12. 10000490 - Inhibitors of the fibroblast growth factor receptor (2018-06-19),

13. 9994552 - Compositions useful for treating disorders related to kit (2018-06-12),

14. 9884861 - Compositions useful for treating disorders related to kit (2018-02-06),

15. 9695165 - Inhibitors of the fibroblast growth factor receptor (2017-07-04),

Hello! Here is an article about the inventor Chandrasekhar V Miduturu.

Title: Innovator Spotlight: Chandrasekhar V Miduturu

Introduction:

Chandrasekhar V Miduturu is a prolific inventor based in Cambridge, MA (US), known for his groundbreaking work in developing compounds to treat various diseases and disorders. With an impressive portfolio of 19 patents, Miduturu continues to push the boundaries of innovation in the pharmaceutical industry.

Latest Patents:

One of his latest patents includes MAP4K1 inhibitors, which are compounds designed to selectively inhibit MAP4K1 activity, offering potential treatment options for diseases and disorders. Additionally, his inventions related to inhibitors of NTRK showcase his commitment to developing therapies for a range of conditions, including resistant mutants of NTRK.

Career Highlights:

Miduturu's career includes significant contributions to leading pharmaceutical companies such as Blueprint Medicines Corporation, where he has played a pivotal role in research and development. His inventive spirit and scientific expertise have been instrumental in shaping the future of pharmaceutical innovation.

Collaborations:

Throughout his career, Miduturu has collaborated with notable industry experts, including coworkers Neil Bifulco and Brian Lewis Hodous. These collaborations have led to the successful development of cutting-edge pharmaceutical solutions and underscore Miduturu's reputation as a collaborative and visionary inventor.

Conclusion:

In conclusion, Chandrasekhar V Miduturu stands out as a pioneering inventor in the field of pharmaceuticals, with a strong focus on developing innovative compounds to address unmet medical needs. His patent portfolio reflects his dedication to advancing healthcare through groundbreaking research and development.

This text is generated by artificial intelligence and may not be accurate.